Publisher's Synopsis
Child Psychopharmacology tackles the ongoing debate over the use of psychotropic medication on child and adolescent disorders. This book reviews the most up-to-date research on the topic and offers practical guidance for treating patients. Some points of interest in this volume include: Discussion of exciting new evidence that OCD may be secondary to betahemolytic streptococcal infections. Thorough coverage of both the benefits and side effects of antipsychotic medications including recent research on clozapine and olanzapine. Thoughtful academic treatment of the effectiveness of antidepressant medications, such as fluxetine, for treating adolescent bulimia.
In a field of study that is controversial and ever changing, Child Psychopharmacology is an invaluable reference. Covering both pharmacological and therapeutic treatment for young patients, this volume addresses these topics with thorough research and care.
